![Scott Stromatt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Stromatt
Nessuna posizione attualmente
Storia della carriera di Scott Stromatt
Precedenti posizioni note di Scott Stromatt
Società | Posizione | Inizio | Fine |
---|---|---|---|
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Direttore Tecnico/Scientifico/R&S | 01/08/2008 | 01/08/2016 |
CTI BIOPHARMA CORP. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 | 01/01/2008 |
Consigliere Generale | 01/01/2003 | 01/01/2008 | |
NORTHWEST BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 02/10/2003 | 02/10/2003 |
C. E. Unterberg, Towbin, Inc.
![]() C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance C. E. Unterberg, Towbin is a global investment bank headquartered in New York City with additional offices in California and Israel. The firm provides investment banking, research and investment management services to emerging growth companies and investors in the technology, health care and defense, security and diversified technology sectors. C. E. Unterberg was founded in 1932 by Clarence Unterberg. In 1977, the firm merged with L. F. Rothschild to form L. F. Rothschild, Unterberg, Towbin. In 1990, the firm again became privately owned and independent when Clarence Unterberg's son, Thomas I. Unterberg, re-launched the firm as a full-service investment bank. | Analyst-Equity | 18/02/2002 | 18/02/2002 |
APTEVO THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2016 | - |
EMERGENT BIOSOLUTIONS INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2010 | - |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Direttore Tecnico/Scientifico/R&S | - | - |
Synergen, Inc. | Direttore Tecnico/Scientifico/R&S | - | - |
C.E. Unterberg, Towbin Holdings, Inc.
![]() C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Part of Canaccord Genuity Group, Inc., C.E. Unterberg, Towbin Holdings, Inc. provides financial advisory services. The company is based in New York, NY. | Corporate Officer/Principal | - | - |
Formazione di Scott Stromatt
The University of Chicago | Doctorate Degree |
The University of Colorado | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Posizioni
Chief Tech/Sci/R&D Officer | 7 |
General Counsel | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
NORTHWEST BIOTHERAPEUTICS, INC. | Health Technology |
EMERGENT BIOSOLUTIONS INC. | Health Technology |
APTEVO THERAPEUTICS INC. | Health Technology |
Aziende private | 6 |
---|---|
CTI BioPharma Corp.
![]() CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
C.E. Unterberg, Towbin Holdings, Inc.
![]() C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Part of Canaccord Genuity Group, Inc., C.E. Unterberg, Towbin Holdings, Inc. provides financial advisory services. The company is based in New York, NY. | Finance |
Synergen, Inc. | Utilities |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
C. E. Unterberg, Towbin, Inc.
![]() C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance C. E. Unterberg, Towbin is a global investment bank headquartered in New York City with additional offices in California and Israel. The firm provides investment banking, research and investment management services to emerging growth companies and investors in the technology, health care and defense, security and diversified technology sectors. C. E. Unterberg was founded in 1932 by Clarence Unterberg. In 1977, the firm merged with L. F. Rothschild to form L. F. Rothschild, Unterberg, Towbin. In 1990, the firm again became privately owned and independent when Clarence Unterberg's son, Thomas I. Unterberg, re-launched the firm as a full-service investment bank. | Finance |
- Borsa valori
- Insiders
- Scott Stromatt
- Esperienza